Can Erdafitinib treat lung cancer?

Erdafitinib (Erdafitinib) is primarily approved to treat urothelial cancer, not lung cancer. Erdafitinib is an oral small molecule kinase inhibitor targeting the fibroblast growth factor receptor (FGFR). Its mechanism involves blocking the abnormally activated FGFR signaling pathway, thereby inhibiting the growth and spread of tumor cells. However, its use in the field of urothelial cancer is now more clear.

Lung cancer is a complex disease, divided into two major types: small cell lung cancer and non-small cell lung cancer (NSCLC), and NSCLC is divided into multiple subtypes. Treatment strategies are often based on the lung cancer subtype, stage, the patient's overall health, and other individual characteristics.

Although FGFR gene abnormalities have been found in some lung cancers, the current research on erdafitinib in the treatment of lung cancer is still in its early stages. Scientists and doctors have been working hard to develop new targeted treatments to more effectively deal with the complexities of lung cancer.

If you are interested in the latest information on erdafitinib in the treatment of lung cancer, it is recommended to consult a professional doctor or consult the latest medical literature and clinical trial data. As scientific research continues to progress, there may be new clinical trials and research results involving the application of erdafitinib in the treatment of lung cancer. Ultimately, a patient's treatment plan should be formulated by a professional physician based on the patient's specific situation and the latest medical information.

Erdafitinib is not currently available in the country, so patients cannot purchase it domestically and need to purchase erdafitinib through foreign channels. The original drug of erdafitinib is mainly the Hong Kong version of the original drug, with a price of more than 20,000, and needs to be purchased through a Hong Kong pharmacy. The generic drugs are relatively cheaper, mainly the Laos version and the Bangladesh Yaopin International version, with a price of about 1,000 to 2,000, and the ingredients of the original drug and the generic drug are basically the same.